A detailed history of Rossby Financial, Lcc transactions in Eli Lilly & CO stock. As of the latest transaction made, Rossby Financial, Lcc holds 1,523 shares of LLY stock, worth $1.56 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
1,523
Previous 1,238 23.02%
Holding current value
$1.56 Million
Previous $965 Million 30.26%
% of portfolio
0.41%
Previous 0.36%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$625.65 - $812.69 $178,310 - $231,616
285 Added 23.02%
1,523 $1.26 Billion
Q2 2025

Aug 01, 2025

BUY
$713.71 - $898.95 $231,242 - $291,259
324 Added 35.45%
1,238 $965 Million
Q1 2025

Apr 28, 2025

BUY
$725.72 - $929.72 $305,528 - $391,412
421 Added 85.4%
914 $808 Million
Q4 2024

Feb 13, 2025

BUY
$727.2 - $932.06 $358,509 - $459,505
493 New
493 $381 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rossby Financial, Lcc Portfolio

Follow Rossby Financial, Lcc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossby Financial, Lcc, based on Form 13F filings with the SEC.

News

Stay updated on Rossby Financial, Lcc with notifications on news.